Showing results (201-210 of 206) with videos related to
Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 206 results.
British Journal of Cancer|July 16, 2009
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancerF Loupakis, A Ruzzo, C Cremolini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokineticsE Wasserman, C Cuvier, F Lokiec, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|September 12, 2017
High concordance of a closed-system, RT-qPCR breast cancer assay for HER2 mRNA, compared to clinically determined immunohistochemistry, fluorescence in situ hybridization, and quantitative immunofluorescenceBrad E Wasserman, Daniel E Carvajal-Hausdorf, Kenneth Ho, et al.Journal of Endocrinological Investigation|May 6, 2018
Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societiesF Pacini, F Basolo, R Bellantone, et al.Journal of Alzheimer'S Disease : JAD|May 14, 2023
Extracellular Tau Oligomers Damage the Axon Initial SegmentMerci N Best, Yunu Lim, Nina N Ferenc, et al.European Journal of Cancer (Oxford, England : 1990)|May 4, 2001
A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patientsA Zori Comba, C Blajman, E Richardet, et al.Pageof 21